Laidlaw is an institution that offers financial solutions to consumers in the UK and US. The organization provides customized guidance on matter concerning wealth and investment banking. Laidlaw & Company currently functions in the United States and the United Kingdom. Its headquarters are found in New York, and it is headed by Mathew Eitner and James Ahern.

Laidlaw and its two principals are known for violating the financial regulations in the US. The financial institution has ruined its reputation in the past, and this has led to numerous customer complaints, monetary penalties, and regulatory sanctions. Many people are beginning to lose their trust in the institution.

Just recently, Relmada Therapeutics, a clinical company in the US decided to file a case at the Nevada District Court against Laidlaw and its two principals. The two companies had a good working relationship, and Laidlaw was the investment banker for Relmada Therapeutics.

After working for several months, the clinical company decided to raise its capital through public funding. As the investment bank for Relmada, Laidlaw was given the responsibility of raising the capital. Relevant documents and information from the clinical company were released to Laidlaw and its principals. However, after the funding activities were completed, Laidlaw decided to claim majority shares in the enterprise. The decision was not taken lightly by the pharmaceutical company.

The lawsuit filed against Laidlaw states that the institution had breached the contract previously signed by the two organizations. This is because Laidlaw has spread confidential and misleading information about Relmada Therapeutics. The investment company failed to comply with the Securities and Exchange Commission regulations. Relmada is now seeking compensation for the losses in incurred after the breach of contract. The Nevada court has already issued a restraining order against Laidlaw and its two principals. If the District Court rules in favor of the clinical company, Laidlaw, and its directors will lose a lot of money.

Categories: Violating Regulations

Comments are Closed on this Post